Basis Partners · Private Equity · 2026
Basis Partners provides managed portfolio monitoring for private equity funds — tracking performance against plan, maintaining valuation discipline, and preparing IC- and LP-ready reporting packs. A dedicated oversight function, without the fixed cost of building one internally.
Most equity losses are not surprises at exit. The signals were present in the portfolio for months — budget slippage, thesis assumptions that quietly stopped holding, management changes that changed the risk profile. The problem is that no structured layer was watching them on a consistent cycle.
PE teams carry the analytical skill to assess these signals. What they often lack is the bandwidth to apply that discipline consistently across the full portfolio, between board meetings, every month.
Investment theses are documented carefully at entry and then rarely revisited in structured form. Revenue assumptions slip, market expansion stalls, management changes — and the team continues working from a narrative the evidence no longer supports.
Receiving a board pack is not the same as monitoring performance. Revenue vs. budget, EBITDA trends, working capital movement, and KPI tracking require a separate analytical layer most teams lack the bandwidth to apply consistently.
IPEV-compliant marks need to be defensible to auditors, LPs, and regulators. Assembling the evidence at quarter-end is slow, incomplete, and carries audit risk. The evidence needs to exist before the conversation starts.
Internal coverage varies with team capacity, deal flow pressure, and staff turnover. Companies that generate less noise get less attention — which is precisely when deterioration goes undetected longest.
Structured monthly monitoring of each investee against budget, plan, and agreed KPIs — with variance commentary, trend flags, and thesis compliance review each cycle.
IPEV-aligned valuation evidence built continuously — not assembled at quarter-end. Methodology, supporting data, and movement narrative ready before the audit conversation starts.
Scored exit readiness tracked each cycle across operational, financial, governance, and market indicators — so gaps are identified years before the exit process, not weeks into it.
Our team has worked across IFC, J.P. Morgan, United Nations programmes, National Treasury South Africa, and investment funds across the continent.
We apply the right monitoring framework to each structure in the portfolio. A buyout position and a convertible instrument have different monitoring requirements, governance mechanics, and value creation levers — our coverage reflects that.
Each structure type carries different covenant mechanics, waterfall positions, and value creation levers. We apply structure-specific monitoring frameworks rather than a single generic template across the book.
Structured view of each company against budget, plan, and agreed KPIs — with variance commentary and trend flags each cycle.
Original investment assumptions reviewed each cycle against current company data — drift flagged with analyst rationale before it compounds.
IPEV-aligned evidence built continuously — methodology, data, and movement narrative ready before quarter-end conversations begin.
Scored exit readiness per company across operational, financial, governance, and market indicators — tracked and updated each cycle.
Full record of board pack receipt, information rights compliance, management team changes, and open governance items.
Packs ready for quarterly LP reporting, IC reviews, and portfolio committee meetings — consistent format and quality each cycle.
| Area | In-house / traditional | Basis Partners |
|---|---|---|
| Performance vs. plan | —Reviewed at board meetings. Budget variances accumulate between meetings without a structured tracking layer. | ✓Structured monthly tracking against budget and plan. Variance flags, trend analysis, and analyst commentary per investee each cycle. |
| Thesis compliance | —Documented at entry and rarely revisited in structured form. Drift accumulates until it surfaces at a portfolio review or an LP question. | ✓Original thesis assumptions reviewed each cycle against current company data. Divergence flagged with analyst rationale before it compounds. |
| Valuation evidence | —Assembled at quarter-end under pressure. Methodology is often retrospective and the audit trail incomplete when questioned by auditors or LPs. | ✓Built continuously throughout the cycle. IPEV-aligned evidence packs exist before the quarter-end conversation begins — not assembled after it starts. |
| Exit readiness | —Assessed informally as exit approaches. No structured scoring or ongoing tracking against defined indicators across the portfolio. | ✓Tracked against defined indicators each cycle. Scoring per company, movement since last review, and readiness gaps flagged ahead of exit conversations. |
| Coverage consistency | —Varies with team capacity, portfolio size, deal flow pressure, and staff turnover. Quieter companies are routinely under-monitored. | ✓Consistent monthly coverage across the full selected cohort, regardless of internal pressure, absences, or competing transaction activity. |
Our team has operated across some of the most rigorous portfolio monitoring environments in Africa and internationally — bringing that discipline to PE funds at every stage of maturity.
We know what good oversight looks like because we built and maintained it inside institutions where the standard was not optional — and where LP scrutiny, audit requirements, and regulatory expectations were live constraints, not abstract principles.
We bring institutional-grade monitoring discipline to funds that need the output quality of a dedicated portfolio management function — without the fixed cost of building one internally. You get consistent coverage, analyst-reviewed outputs, and defensible valuations, regardless of team capacity.
We begin with a focused diagnostic across a selected cohort of portfolio companies — so you see real analyst work on your actual portfolio before deciding whether to expand the mandate.
Choose two to five portfolio companies — a mix of strong performers, concerns, and upcoming exits. We work from your existing IC papers, board packs, and financial statements. No new data requirements.
Full analyst-reviewed output across the selected cohort — performance vs. plan, thesis compliance, valuation evidence, exit readiness scorecard, and governance log. Delivered within an agreed timeframe.
Review the output with your team. If it adds value, we expand the mandate across the full portfolio on a monthly or quarterly cycle. If not, you keep everything produced during the diagnostic. No obligation either way.